QuickView for error-free translesion synthesis (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
2. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
5. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens

1. Oxidative DNA damage bypass in Arabidopsis thaliana requires DNA polymerase λ and proliferating cell…
2. Role of yeast Rad5 and its human orthologs, HLTF and SHPRH in DNA damage tolerance.
3. The molecular chaperone Hsp90 regulates accumulation of DNA polymerase eta at replication stalling s…
4. Structure of the human Rev1-DNA-dNTP ternary complex.
5. DNA polymerases eta and kappa are responsible for error-free translesion DNA synthesis activity over…

There were no clinical trials for error-free translesion synthesis